Fatigue and aging

Critical Reviews in Oncology/Hematology

Volumn 48, Issue SUPPL., 2003, Pages

  Tralongo, Paolo ^a   Respini, Daniela ^a   Ferraù, Francesco ^a  

^a G Di Maria Hospital   (Italy)

Author keywords

Cancer patients; Elderly; Fatigue

Indexed keywords

AMIFOSTINE; ANTIANDROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CISPLATIN; CORTICOSTEROID; DOCETAXEL; GEMCITABINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRINOTECAN; METHYLPHENIDATE; NAVELBINE; RECOMBINANT COLONY STIMULATING FACTOR; SOMATOMEDIN C; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGING; ANEMIA; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONFERENCE PAPER; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; DISABILITY; DISEASE SEVERITY; ENDOCRINE DISEASE; EXERCISE; FATIGUE; HOME CARE; HUMAN; INCIDENCE; LUNG NON SMALL CELL CANCER; METABOLIC DISORDER; MUSCLE ATROPHY; PREVALENCE; PROSTATE CANCER; QUALITY OF LIFE; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 0141987845     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2003.07.003     Document Type: Conference Paper

References (98)

1. Nail L.M., King K.B. Fatigue. Semin Oncol. Nurs. 3:1987;257-262.
2. Grandjean E. Fatigue: its physiological and psychological significance. Ergonomics. 11:1968;427-436.
3. Piper BF. Fatigue. In: Carrier VK, Linddsey AM, West CM, editors. Pathophysiological phenomena in nursing. Philadelphia: Saunders; 1962. p. 219-34.
4. Dorland's illustrated medical dictionary, 25th ed. Philadelphia: Saunders; 1974.
5. Fukuda K., Strass S.E., Hickie I.B.et al. The Cronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121:1994;953-959.
6. Cella D., Partemon A., Passik S.et al. Progress toward guidelines for the management of fatigue. Oncology. 12:1998;1-9.
7. Kaasa S., Loge J., Knobel H.et al. Fatigue. Measures and relation to pain. Acta Anestesiol. Scand. 43:1999;939-947.
8. Smets E., Garsen B., Schuster-Uitterhoeve A.et al. Fatigue in cancer patients. Br. J. Cancer. 68:1993;220-224.
9. Berglund G., Bolund C., Fornander T.et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur. J. Cancer. 27:1991;1075-1081.
10. Jones TH, Wadler S, Hupart KH. Endocrine-mediate mechanisms of fatigue during treatment with interferon-α, Semin Oncol 25(Suppl 1):54-63.
11. Servaes P., van-der-Werf S., Prinset al. Fatigue in disease-free cancer patients compared with fatigue in patients with Chronic Fatigue Syndrome. Support Care Cancer. 9:2000;11-17.
12. Hann D.M., Jacobsen P.B., Azzarello L.M.et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual. Life Res. 7:1998;301-310.
13. Rothen D. Fatigue and the post surgical patients. In: Norris CM, editor. Concept clarification in nursing. Rockville (MD): Aspen Publisher Inc.; 1982. p. 227-300.
14. Piper BF, Lindsey AM, Dodd MJ, et al. The development of an instrument to measure the subjective dimension of fatigue. In: Funk SG, Tournquist EM, Shampagne MT, Kopp LA, Weis RA, editors. Key aspects of comfort: management of pain, fatigue and nausea. New York: Springer-Verlag; 1989. p. 199-208.
15. Pearson PG, Bjars GE. The development and validation of a checklist measuring subjective fatigue (Report no. 56-115). Randolf AFB (TX): School of aviation, USAF; 1956.
16. Smets E.M., Garssen B., Bonke B.et al. The multidimensional fatigue inventory (MFI). Psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39:1995;315-325.
17. Mendoza T.R., Wang X.S., Cleeland C.S.et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer. 85:1999;1186-1196.
18. Yellen B., Cella D.F., Webster K.et al. Measuring Fatigue and other anemia related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J. Pain Symptom Manage. 13:1997;63-74.
19. Overeach J, Parr J, Perry J, et al. Validity and reliability of the FACT-G SCALE for use in the older pt with cancer. In: Proceedings of the 3rd International Conference an Geriatric Oncology, Tampa, FL, November 1996.
20. Aistars I. Fatigue in the cancer patients: a conceptual approach to a clinical problem. Oncol. Nurs. Forum. 14:1987;25-30.
21. Yellen S.B., Cella D.F., Webster K.et al. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J. Pain Symptom Manage. 13:1991;63-74.
22. Irvine D.M., Vincent L., Bubela N.et al. A critical appraisal of the research literature investigative in the individual with cancer. Cancer Nurs. 14:1991;188-199.
23. Irvine D., Vincent L., Graydon J.E.et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experience by health individuals. Cancer Nurs. 17:1994;367-378.
24. Knobf M.T. Physical and psychological distress associated with adjuvant chemotherapy in women with breast cancer. J. Clin. Oncol. 4:1986;678-684.
25. Hayloch P.J., Hart L.K. Fatigue in patients receiving localized radiotherapy. Cancer Nurs. 2:1979;461-467.
26. Greenberg D.B., Sawicka J., Eisenthal S.et al. Fatigue syndrome due to localized radiotherapy. J. Pain Symptom Manage. 7:1992;38-45.
27. Portenoy R.K., Thaler H.T., Kornblith A.B.et al. Pain in ovarian cancer: prevalence, characteristics, and associated symptoms. Cancer. 74:1994;907-915.
28. Curtis E.B., Kretch R., Walsh T.D. Common symptoms in patients with advanced cancer. J. Palliat. Care. 7:1991;25-29.
29. Dunphy K.P., Amesbury B.D.W. A comparison of hospice and homecare patients: patterns of referral, patients characteristics and predictors of place of death. Palliat. Med. 4:1990;105-111.
30. Ventafridda V., DeConno F., Ripamonti C.et al. Quality of life assessment during a palliative care program. Ann. Oncol. 1:1990;415-420.
31. Dunlop G.M. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far-advanced cancer: student paper. Palliat. Med. 4:1989;37-43.
32. Portenoy R.K., Thaler H.T., Kornblith A.B.et al. Symptom prevalence, characteristics, and distress in a cancer population. Qual. Life Res. 3:1994;183-189.
33. Vogelzang N.J., Breitbart W., Cella D.et al. Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol. 34(3):1997;4-12.
34. Curt G.A., Breitbart W., Cella D.et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 5:2000;353-360.
35. Liao S., Ferrell B.A. Fatigue in an older population. J. Am. Ger. Soc. 48:2000;426-430.
36. Respini D, Jacobsen P, Thors C, Tralongo P, Balducci L. Fatigue in older cancer patients. In: Proceedings of the Paper Presented at the Conference on Cancer in the Elderly, Lyon, France, 14-15 September 2001 [abstract 30].
37. Respini D, Tralongo P, Di Mari A. Fatigue and depression in older cancer patients treated with chemotherapy. In: Proceedings of the Paper Presented at the UICC International Cancer Congress, Oslo, 2002 [abstract 0112].
38. Stone P., Richards M., Hardy J. Fatigue in patients with cancer. Eur. J. Cancer. 34:1998;1670-1676.
39. Bruera E., Schimtz B., Pither J.et al. The frequency and correlates of dyspnea. J. Pain Symptom Manage. 19:2000;357-362.
40. Okuyama T., Akechi T., Kagaya A.et al. Factors correlates with fatigue in disease-free breast cancer patients: application of the cancer fatigue scale. Support Care Cancer. 8:2000;215-222.
41. Stone P., Richards M., Hardy J.et al. A study to investigate the cancer prevalence severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann. Oncol. 11:2000;561-567.
42. Smets E.M., Visser M.R., Willems G.A.et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br. J. Cancer. 78:1998;899-906.
43. Richardson A., Ream E., Wilson B.J. Fatigue in patients receiving chemotherapy: patterns of change. Cancer Nurs. 21:1998;17-30.
44. Hann D.M., Garovoy N., Finkelstein B., Jacobsen P.B.et al. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. J. Pain Symptom Manage. 17:1999;311-319.
45. Jacobsen P.B., Hann D.M., Azzarello L.M. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J. Pain Symptom Manage. 18:1999;233-242.
46. Stone P., Hardy J., Broadley K. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br. J. Cancer. 79:1999;1479-1486.
47. Broeckel J.A., Jacobsen P.B., Horton J., Balducci L.et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 16:1998;1689-1696.
48. Loge J.H., Abrahamsen A.F., Ekeberg O.et al. Hodgkin's disease survivors more fatigued than general population. J Clin. Oncol. 17:1999;253-261.
49. Woo B., Dibble S.L., Piper B.F.et al. Differences in fatigue by treatments methods in women with breast cancer. Oncol. Nurs. Forum. 25:1998;915-920.
50. Howell S.J., Radford J.A., Smets E.M.et al. Fatigue sexual function and mood following treatment for hematological malignancy: the impact of mild Leyding cell dysfunction. Br. J. Cancer. 82:2000;789-793.
51. Cella D., Davis K., Breibart W.et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J. Clin. Oncol. 19:2001;3385-3391.
52. Graydon J.E., Bubela N., Irvine D. Fatigue-reducing strategies used by patients receiving treatment for cancer. Cancer Nurs. 18:1995;23-28.
53. Dean G.E., Spears L., Ferrel B.R.et al. Fatigue in patients with cancer receiving interferon alpha. Cancer Pract. 3:1995;164-172.
54. Irvine D.M., Vincent L., Graydon J.E. Postoperative pain and fatigue after laparoscopic or conventional colorectal resections. A prospective randomized trial. Surg. Endosc. 12:1998;1131-1136.
55. Jakeways M.S., Mitchell V., Hashim I.A.et al. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet. 345:1995;763-764.
56. Gaston-Johansson F., Fall-Dickson J.M., Bakos A.B. Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. Br. J. Surg. 81:1994;127-131.
57. Berger A.M. Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs. 21:1998;127-135.
58. Bardram L., Funch-Jensen P., Jensen P.et al. Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: implications for management. J. Pain Symptom Manage. 11:1996;370-377.
59. Dreisbach A.W., Hendrickson T., Beezhold D.et al. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br. J. Cancer. 78:1998;907-912.
60. Chan C.W.K., Malassiotis A. The impact of fatigue on Chinese cancer patients in Hong Kong. Support Care Cancer. 19:2000;18-24.
61. Cella DF, Lai J-S, Chang CH, et al., Fatigue in cancer patients compared with fatigue in the general population, Cancer 2002, 528-538.
62. Okuyama T., Tanaka K., Akechi T.et al. Fatigue in ambulatory patients with advanced lung cancer, prevalence correlated factors and screening. J. Pain Symptom Manage. 22:2001;554-564.
63. Mor V., Allen S., Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer. 74(Suppl):1994;2118-2127.
64. Hann D.M., Jacobsen P., Martin S. Fatigue and quality of life following radiotherapy for breast cancer: a comparative study. J. Clin. Psychol. Med. Settings. 5:1998;19-33.
65. Hann D.M., Jacobsen P.B., Martin S.C.et al. Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer. 5:1997;44-52.
66. Visser M.R., Smets E.M. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer. 6:1998;101-108.
67. Monga U., Kerrigan A.J., Thorby J.et al. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat. Oncol. Invest. 7:1999;178-185.
68. Stone P., Hardy J., Huddart R. Fatigue in patients with prostate cancer receiving hormone therapy. Eur. J. Cancer. 36:2000;1134-1141.
69. Sharpe M., Hawton K., Clements A.et al. Increased brain serotonin function in men with cronic fatigue syndrome. Br. Med. J. 315:1997;164-165.
70. Bakheit A., Behan P., Dinan T.et al. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br. Med. J. 304:1992;1010-1012.
71. Cleare A., Bearn J., Allain T.et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect Disord. 35:1995;283-289.
72. Bailey S.P., Davis J.M., Ahlborn E.N. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol. Scand. 145:1992;75-76.
73. Bakheit A., Behan P., Dinan T.et al. Possible upregulation of hypotalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br. Med. J. 304:1992;1010-1012.
74. Morrow GR, Hichok JT, et al. Effect of an SSRIs antidepressant on fatigue and depression in seven hundred thirty-eight cancer patients treated with chemotherapy: a URCC CCOP study. In: Proceedings of the American Society Clinical Oncology, San Francisco, 2001 [abstract 1351].
75. Servaes P., Verhagen P., Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann. Oncol. 13:2002;589-598.
76. Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol. 25(Suppl 7):1998;43-46.
77. Zucker S. Anemia in cancer. Cancer Invest. 3:1985;249-260.
78. Hymon G.A., Gellhorn A., Horvey J.L. Studies on the anemia of disseminated malignant neoplastic disease. II. Study of the life span of the erythrocyte. Blood. 11:1956;618-631.
79. Salvarini C., Casali B., Salvo D.et al. The role of interleukin-1, erythropoietin and red cell board immunoglobulins in the anemia of rheumatoid arthritis. Clin. Exp. Rheumatol. 9:1991;241-246.
80. Cannan J.G., Angel J.B., Ball R.W.et al. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J. Clin. Immunol. 19:1999;414-421.
81. Moss R.B., Mercadetti A., Vojdani A. TNF-alpha and chronic fatigue syndrome. J. Clin. Immunol. 19:1999;314-316.
82. Mac Donald K.L., Ostarholm M.T., LeDell K.H.et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am. J. Med. 100:1996;548-554.
83. Spath-Schwalbe E., Hansen K., Schmidt F.et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol Metab. 83:1998;1573-1579.
84. Martin F. Fraily and somatopause growth hormone. IGF Res. 9:1999;10-30.
85. Lynch N.A., Metter E.J., Lindle R.S.et al. Age-associated differences between arm and leg muscle group. J. Appl. Physiol. 86:1999;188-194.
86. Roubenoff R., Hughes V.A. Sarcopenia: current concepts. J. Geronthol. 55:2000;M716-M724.
87. Brown W.F. A method for estimate the number of motor units in thenar muscle and the changes in motor unit count with aging. J. Neurol. Neurosurg. Psychol. 35:1972;845-852.
88. Monga U., Jaweed M., Kerrigan A.J.et al. Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Arc. Phys. Med. Rehabil. 78:1997;961-966.
89. Bruera E., Brenneis C., Michaud M. Muscle electrophysiology in patients with advanced breast cancer. J. Natl. Cancer Inst. 80:1988;282-285.
90. Glaspy J., Bukowski R., Steinberg D., Taylor C. Impact of therapy with epoietin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J. Clin. Oncol. 15:1997;1218-1234.
91. Demetri G.D., Kris M., Wade J.et al. Quality-of-life benefit in chemotherapy patients treated with epoietin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J. Clin. Oncol. 16:1998;3412-3425.
92. Littlewood T.J., Bajetta E., Nortier J.W.R.et al. Effects of epoietin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomised double-blind placebo-controlled trial. J. Clin. Oncol. 11:2001;2865-2874.
93. Gabrilove J.L., Cleeland C.S., Livingstone R.B.et al. Clinical evaluation of once-weekly dosing of epoietin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J. Clin. Oncol. 11:2001;2875-2882.
94. Dionne L.J., Kinaman K.A., Phoehlman E.T. Sarcopenia and muscle function during menopause and hormone-replacement therapy. J. Nutr. Health Aging. 4:2000;156-161.
95. Sato S., Yokoyama A., Ohtsuka T.et al. A case of primary hyperparathyroidism that had been treated under a diagnosis of depression for 10 years. Psychiatr. Clin. Neurosci. 49:1995;147-149.
96. Valentine A.D., Meyers C.A. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 92:2001;1694-1698.
97. Dimeo F., Stieglitz R.D., Novelli-Fischer U.et al. Effects of physical activity on the fatigue and psycologic status of cancer patients during chemotherapy. Cancer. 85:1999;2273-2277.
98. Bruera E., Driver L., Barnes E. Patient controlled methylphenidate (PCM) for cancer-related fatigue. Proc Am Soc Clin Oncol. 22:2003;737.